Merrimack Price To Book Ratio from 2010 to 2024

MACK Stock  USD 14.77  0.02  0.14%   
Merrimack Pharmaceuticals Price To Book Ratio yearly trend continues to be quite stable with very little volatility. Price To Book Ratio may rise above 10.74 this year. Price To Book Ratio is a ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter’s book value per share. View All Fundamentals
 
Price To Book Ratio  
First Reported
2010-12-31
Previous Quarter
10.22828133
Current Value
10.74
Quarterly Volatility
15.37731535
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Merrimack Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merrimack main balance sheet or income statement drivers, such as Total Revenue of 0.0, Other Operating Expenses of 2.1 M or Cost Of Revenue of 380.5 K, as well as many exotic indicators such as Price To Sales Ratio of 3.05, Dividend Yield of 0.31 or Price Book Value Ratio of 10.74. Merrimack financial statements analysis is a perfect complement when working with Merrimack Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement Merrimack Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Merrimack Pharmaceuticals Technical models . Check out the analysis of Merrimack Pharmaceuticals Correlation against competitors.
For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.

Latest Merrimack Pharmaceuticals' Price To Book Ratio Growth Pattern

Below is the plot of the Price To Book Ratio of Merrimack Pharmaceuticals over the last few years. It is a ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter’s book value per share. Merrimack Pharmaceuticals' Price To Book Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merrimack Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Price To Book Ratio10 Years Trend
Slightly volatile
   Price To Book Ratio   
       Timeline  

Merrimack Price To Book Ratio Regression Statistics

Arithmetic Mean(2.44)
Coefficient Of Variation(629.46)
Mean Deviation8.82
Median0.69
Standard Deviation15.38
Sample Variance236.46
Range64.2932
R-Value0.59
Mean Square Error166.08
R-Squared0.35
Significance0.02
Slope2.03
Total Sum of Squares3,310

Merrimack Price To Book Ratio History

2024 10.74
2023 10.23
2022 8.05
2021 3.7
2020 5.76
2019 2.43
2018 0.69

About Merrimack Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Merrimack Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Merrimack Pharmaceuticals investors use historical funamental indicators, such as Merrimack Pharmaceuticals's Price To Book Ratio, to determine how well the company is positioned to perform in the future. Although Merrimack Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Merrimack Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Merrimack Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Merrimack Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Merrimack Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Price To Book Ratio 10.23  10.74 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Merrimack Pharmaceuticals is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Merrimack Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Merrimack Pharmaceuticals Stock. Highlighted below are key reports to facilitate an investment decision about Merrimack Pharmaceuticals Stock:
Check out the analysis of Merrimack Pharmaceuticals Correlation against competitors.
For more information on how to buy Merrimack Stock please use our How to buy in Merrimack Stock guide.
Note that the Merrimack Pharmaceuticals information on this page should be used as a complementary analysis to other Merrimack Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Merrimack Stock analysis

When running Merrimack Pharmaceuticals' price analysis, check to measure Merrimack Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merrimack Pharmaceuticals is operating at the current time. Most of Merrimack Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Merrimack Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merrimack Pharmaceuticals' price. Additionally, you may evaluate how the addition of Merrimack Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Stocks Directory
Find actively traded stocks across global markets
Is Merrimack Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merrimack Pharmaceuticals. If investors know Merrimack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merrimack Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.08)
Return On Assets
(0.07)
Return On Equity
(0.06)
The market value of Merrimack Pharmaceuticals is measured differently than its book value, which is the value of Merrimack that is recorded on the company's balance sheet. Investors also form their own opinion of Merrimack Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Merrimack Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merrimack Pharmaceuticals' market value can be influenced by many factors that don't directly affect Merrimack Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merrimack Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Merrimack Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merrimack Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.